Cyclacel Pharmaceuticals's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to release its latest quarterly earnings report on August 9, 2023. Analysts estimate an earnings per share (EPS) of $-0.50. The company's past performance shows a pattern of share price drops following earnings reports, despite beating EPS estimates. The company's shares are currently trading at $0.592 and have fallen 54.66% over the last 52-week period.
August 08, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Cyclacel Pharmaceuticals is expected to report an EPS of $-0.50 in its upcoming earnings report. The company's shares have been on a downward trend, falling 54.66% over the past year.
Cyclacel Pharmaceuticals has a history of share price drops following earnings reports, despite beating EPS estimates. Given the analysts' EPS estimate of $-0.50 and the company's negative stock performance over the past year, it is likely that the upcoming earnings report could further negatively impact the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100